And Merck's business extends beyond this single product. The company recently earned approval for Winrevair, a therapy for pulmonary arterial hypertension with a new mechanism of action.

“DNA repair defects are a frequent hallmark of tumour cells and a major cause of resistance to cancer therapy,” said Dr David Weinstock, Vice President, Discovery Oncology, Merck Research Laboratories ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired ... of Healthcategory US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder November 13, 2024 Future of Healthcategory ...

(Reuters) - Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of ...

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical study evaluating the investigational combination of islatravir and ...

Merck (NYSE:MRK) also announced interim data from a Phase 3 trial testing clesrovimab against RSV therapy palivizumab in infants and children at a higher risk for severe RSV disease. As for the ...

Three months after revealing that its respiratory syncytial virus (RSV) preventive antibody clesrovimab had passed muster in a phase 2b/3 trial, Merck is putting numbers to the claim. Clesrovimab ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

German pharma and technology giant Merck has announced a €5 million ... the world's largest manufacturer of mAbs for blood typing diagnosis, producing approximately 25 tonnes of antibodies ...

thanks to her first therapy session. The "Real Housewives of Orange County" star revealed that she was on the Autism spectrum disorder thanks to a new diagnosis. She dropped the health update on ...

Addition of CN201, a next generation CD3xCD19 bispecific antibody with potential applications in B-cell malignancies and autoimmune diseases, broadens and fortifies Merck’s pipeline RAHWAY, ...